Fiera Capital (Canada)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.7M | Sell |
490,594
-3,881
| -0.8% | -$488K | 0.21% | 74 |
|
|
2025
Q1 | $54.7M | Sell |
494,475
-4,634
| -0.9% | -$513K | 0.2% | 71 |
|
|
2024
Q4 | $68.1M | Sell |
499,109
-17,692
| -3% | -$2.41M | 0.21% | 71 |
|
|
2024
Q3 | $59.5M | Sell |
516,801
-11,101
| -2% | -$1.28M | 0.18% | 78 |
|
|
2024
Q2 | $72.7M | Buy |
527,902
+16,360
| +3% | +$2.25M | 0.23% | 65 |
|
|
2024
Q1 | $70.6M | Sell |
511,542
-5,323
| -1% | -$734K | 0.21% | 71 |
|
|
2023
Q4 | $68.1M | Buy |
516,865
+5,497
| +1% | +$724K | 0.21% | 67 |
|
|
2023
Q3 | $57.5M | Buy |
511,368
+153,393
| +43% | +$17.3M | 0.18% | 67 |
|
|
2023
Q2 | $33.8M | Sell |
357,975
-11,392
| -3% | -$1.07M | 0.1% | 116 |
|
|
2023
Q1 | $37.4M | Sell |
369,367
-3,152
| -0.8% | -$319K | 0.11% | 104 |
|
|
2022
Q4 | $44.5M | Sell |
372,519
-2,568
| -0.7% | -$307K | 0.14% | 82 |
|
|
2022
Q3 | $37.5M | Sell |
375,087
-3,719
| -1% | -$372K | 0.13% | 85 |
|
|
2022
Q2 | $36.9M | Sell |
378,806
-4,880
| -1% | -$476K | 0.11% | 96 |
|
|
2022
Q1 | $36M | Buy |
383,686
+19,814
| +5% | +$1.86M | 0.09% | 126 |
|
|
2021
Q4 | $31M | Sell |
363,872
-38,600
| -10% | -$3.29M | 0.07% | 145 |
|
|
2021
Q3 | $38.6M | Sell |
402,472
-6,390
| -2% | -$613K | 0.1% | 111 |
|
|
2021
Q2 | $39.8M | Sell |
408,862
-9,348
| -2% | -$910K | 0.1% | 114 |
|
|
2021
Q1 | $40.7M | Buy |
418,210
+5,934
| +1% | +$577K | 0.12% | 113 |
|
|
2020
Q4 | $39.5M | Buy |
412,276
+126,651
| +44% | +$12.1M | 0.11% | 124 |
|
|
2020
Q3 | $27.5M | Buy |
+285,625
| New | +$27.5M | 0.08% | 142 |
|